Indometacin farnesil

吲哚美辛法尼酯

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameIndometacin farnesil
Drug Alias NameIndomethacin farnesilDialonInfreeE-0710
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCyclooxygenase-1 inhibitorsCyclooxygenase-2 inhibitors
TargetsCyclooxygenase-2Cyclooxygenase-1
Therapy Area/IndicationsPainInflammation
Global Approved IndicationsPainInflammation
Approved Indications in ChinaN/A
Original Approved Country/TerritoryJapan
Original Approved Date1991/03/29
Country/TerritoryJapan
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesEisai Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesEisai Co Ltd
Inactive CompaniesN/A
Active IndicationsPainInflammation
Inactive IndicationsN/A

Other Information

ATC CodeC01EB03M01AB01M02AA23 +[4] 
Related LinksWikipediaDrugBankKEGG